10 mg Strength
Labeled at 10 mg of Cagrilintide per vial.
Dragon Pharma
You will save $40.00
Cagrilintide 10 mg
Long-Acting Amylin Analog (Research Peptide)
- Product: Cagrilintide 10 mg
- Active Substance: Cagrilintide Acetate
- Strength: 10 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$60.00
$100.00
Warehouse :
International
U.S. Domestic
Dragon Pharma Lyophilized Peptide
Dragon Pharma Cagrilintide 10 mg Overview
Dragon Pharma Cagrilintide 10 mg is supplied in a 2 mL vial and contains the long-acting amylin analog Cagrilintide at a labeled strength of 10 mg per vial. Product specifications, a published lab report, storage information, and other practical product details are provided below.
2 mL Vial
Supplied as a lyophilized powder in a sealed, sterile 2 mL vial.
Lyophilized Form
The product is presented as a freeze-dried powder requiring reconstitution before use.
Published Lab Report
A published lab report provides a measured result for the tested batch.
Product Specifications
| Product name | Cagrilintide 10 mg |
|---|---|
| Active substance | Cagrilintide Acetate |
| Labeled strength | 10 mg/vial |
| Container | 2 mL vial |
| Product form | Lyophilized powder |
| Manufacturer | Dragon Pharma |
Published Test Result
The latest published report for batch #CGDHD7, dated September 13, 2024, measured 9.39 mg against the stated 10 mg concentration. Open the Lab Reports tab to view the full report.
Related Peptide Products
Other peptide products in the Dragon Pharma range include the amylin analog Mazdutide, the dual GIP/GLP-1 receptor agonist Survodutide, and the GLP-1 receptor agonist Semaglutide.
Each peptide has a distinct amino acid sequence and is studied for its specific biological activity.
Published Testing
Dragon Pharma Cagrilintide 10 mg Lab Reports
A published lab report for Dragon Pharma Cagrilintide 10 mg is provided below with the test date, measured result and reported batch number. The result can be compared directly with the product's labeled strength of 10 mg/vial.
Published Report
September 13, 2024 Laboratory Test
- Label claim
- 10 mg
- Measured result
- 9.39 mg
- Measured vs. label
- 93.90%
- Batch
- #CGDHD7
- Test date
Science & Research
Understanding Cagrilintide
Cagrilintide is a long-acting analog of the naturally occurring hormone amylin. It is being investigated as a potential therapeutic for weight management.
Amylin Analog
Cagrilintide is a synthetic peptide that mimics the activity of the naturally occurring hormone amylin, which is co-secreted with insulin from the pancreas.
Receptor Activation
It acts as an agonist at amylin receptors in the hindbrain and hypothalamus, which are involved in appetite regulation and satiety signaling.
Clinical Investigation
Cagrilintide is in Phase 3 clinical development by Novo Nordisk for the treatment of obesity and overweight, with data showing clinically meaningful weight loss.
Mechanism of Action
Amylin is a 37-amino acid peptide that is co-secreted with insulin from pancreatic beta cells in response to nutrient intake. Once secreted, it activates receptors in the hindbrain and hypothalamus to induce satiation, and it also impacts glucose control by suppressing glucagon secretion and delaying gastric emptying. Cagrilintide is a long-acting analog of human amylin that has been modified to improve its chemical stability and circulating half-life. It acts by binding to amylin receptors (AMY1-3) to suppress appetite and promote satiety.
The product is supplied as a lyophilized powder at a labeled strength of 10 mg per vial.
Research Context
Cagrilintide is not an anabolic steroid or a hormone like testosterone or growth hormone. It is an investigational amylin analog with a mechanism of action distinct from these compounds, acting on appetite regulation through amylin receptors in the brain.
Medical and Research References
Cagrilintide is in Phase 3 clinical development for obesity and overweight. ClinicalTrials.gov provides study details and data on its safety and efficacy.
Important Health Information
Cagrilintide 10 mg Safety Information
Peptide products should be handled with appropriate care, particularly when being reconstituted for use.
Reconstitution and Injection
Following the correct reconstitution procedure and using sterile handling techniques is essential to minimize the risk of contamination.
Gastrointestinal Effects
In clinical studies, common side effects of cagrilintide include nausea, vomiting, diarrhea, decreased appetite, and constipation. These are generally mild to moderate and often more pronounced during dose escalation.
Limited Clinical Data
Clinical data on the safety, efficacy, and appropriate dosing of this specific peptide is limited outside of formal clinical trials. The risk profile is not as well-defined as that of more established drugs.
Allergic Reactions
As with any peptide or protein-based product, there is a potential for hypersensitivity. Discontinue use and seek medical advice if signs of an allergic reaction develop.
Medical Consultation
Discussing any new product, including peptide compounds, with a healthcare professional is recommended before use.
General Precautions
Cagrilintide is not intended to diagnose, treat, cure, or prevent any disease. It should be handled as a research compound. Individuals with known allergies to peptides should exercise caution.
The product should be stored securely to prevent accidental access or use by children or other household members.
Tested Sport
As a peptide with limited established clinical use, its status under anti-doping rules may vary. Athletes should check the current WADA Prohibited List before competition.
Common Product Questions
Dragon Pharma Cagrilintide 10 mg FAQ
Quick answers about Cagrilintide 10 mg specifications, the published lab report, storage, shipping, Bitcoin payment, and general product information.
What is Dragon Pharma Cagrilintide 10 mg?
Dragon Pharma Cagrilintide 10 mg is a lyophilized peptide product containing the long-acting amylin analog Cagrilintide at a labeled strength of 10 mg per vial. It is supplied in a sterile 2 mL vial.
What is Cagrilintide?
Cagrilintide is a long-acting analog of the naturally occurring hormone amylin. It acts on amylin receptors in the brain to suppress appetite and induce satiety.
How is Cagrilintide 10 mg supplied?
The product is supplied as a lyophilized powder in a 2 mL vial that requires reconstitution with a suitable diluent before use.
What did the latest lab report show?
The published report, dated September 13, 2024, measured 9.39 mg for batch #CGDHD7. This corresponds to approximately 93.90% of the stated 10 mg concentration.
Does a lab report verify every vial?
No. Each report applies to the sample submitted for that specific test and the batch identified in the report. It does not independently verify the content or condition of every individual vial.
How should Cagrilintide 10 mg be stored?
Store the lyophilized powder in its original packaging at room temperature, protected from heat, moisture, and direct light. Once reconstituted, follow the storage instructions provided with the diluent.
Does Cagrilintide 10 mg contain hormones?
No. Cagrilintide is a peptide that mimics the hormone amylin but does not act as an anabolic steroid or growth hormone.
Is Cagrilintide permitted in tested sport?
As a peptide with limited established clinical use, its status under anti-doping rules may vary. Athletes should check the current WADA Prohibited List before competition.
How long does Cagrilintide 10 mg delivery take?
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Can I buy Cagrilintide 10 mg with Bitcoin?
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy Cagrilintide 10 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Is Bitcoin payment anonymous?
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Where can I find official Cagrilintide information?
Clinical study information is available from sources such as ClinicalTrials.gov. Direct links to relevant resources are provided in the Science & Research section above.
No reviews found
Please log in to write Cagrilintide 10 mg review.
Related Offers
Domestic & International
-40% OFF
Dragon Pharma, Europe
Growth Hormone Fragment Research Peptide
- Product: AOD 9604 5 mg
- Active Substance: AOD9604
- Strength: 5 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$42.00
$70.00
Domestic & International
NEW
-40% OFF
Dragon Pharma, Europe
AMPK Activator Research Compound
- Product: AICAR 50 mg
- Active Substance: AICAR
- Strength: 50 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$39.00
$65.00
Domestic & International
NEW
-40% OFF
Dragon Pharma, Europe
Peptide Research Compound
- Product: Adipotide 10 mg
- Active Substance: Adipotide
- Strength: 10 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$51.00
$85.00